# ASCO HBV Screening and Management for Patients With Cancer Prior to Therapy

OpenHBV source page: https://openhbv.bangbo.dev/sources/asco-hbv-screening-and-management-for-patients-with-cancer-prior-to-therapy?locale=en
Canonical Markdown: https://openhbv.bangbo.dev/sources/asco-hbv-screening-and-management-for-patients-with-cancer-prior-to-therapy.md?locale=en
Original URL: https://ascopubs.org/doi/10.1200/JCO.20.01757

## Metadata

- Organization: American Society of Clinical Oncology
- Country or region: United States
- Language: en
- Source type: guideline
- Published: not listed
- Source updated: not listed
- Last checked by OpenHBV: 2026-06-26
- Credibility note: 专业肿瘤学会临床指导

## Summary

ASCO 关于癌症系统治疗前乙肝筛查和管理的临床意见更新，建议系统抗癌治疗前进行 HBsAg、anti-HBc 和 anti-HBs 检测，并根据风险管理。

## Related OpenHBV Articles

- Before chemotherapy, immunosuppression, or biologics: do not miss hepatitis B reactivation risk
  URL: https://openhbv.bangbo.dev/articles/before-chemotherapy-immunosuppression-or-biologics-do-not-miss-hepatitis-b-reactivation-risk?locale=en
  Markdown: https://openhbv.bangbo.dev/articles/before-chemotherapy-immunosuppression-or-biologics-do-not-miss-hepatitis-b-reactivation-risk.md?locale=en
  Translation key: article-8c0fbf61e461
  Language: en
  Topic: Treatment and Follow-up
  Published: 2026-06-26
  Review status: source_backed
  Last reviewed: 2026-06-26
  Summary: What HBV reactivation means, which treatments should trigger screening, and what to ask before cancer or immune-suppressing therapy starts.

## Use Notes

This page is a source record, not medical advice. Use the original source URL above to verify claims, publication details, updates, and scope. OpenHBV records the last checked date so readers and LLM retrieval systems can judge freshness.